These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20678515)

  • 1. KST5468, a new T-type calcium channel antagonist, has an antinociceptive effect on inflammatory and neuropathic pain models.
    Lee MJ; Shin TJ; Lee JE; Choo H; Koh HY; Chung HJ; Pae AN; Lee SC; Kim HJ
    Pharmacol Biochem Behav; 2010 Dec; 97(2):198-204. PubMed ID: 20678515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain.
    Matthews EA; Bee LA; Stephens GJ; Dickenson AH
    Eur J Neurosci; 2007 Jun; 25(12):3561-9. PubMed ID: 17610575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
    Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
    Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of T-type calcium channel in the development of neuropathic pain following chronic compression of rat dorsal root ganglia.
    Wen XJ; Xu SY; Chen ZX; Yang CX; Liang H; Li H
    Pharmacology; 2010; 85(5):295-300. PubMed ID: 20453553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats.
    Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z
    Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive curcuminoid, KMS4034, effects on inflammatory and neuropathic pain likely via modulating TRPV1 in mice.
    Lee JY; Shin TJ; Choi JM; Seo KS; Kim HJ; Yoon TG; Lee YS; Han H; Chung HJ; Oh Y; Jung SJ; Shin KJ
    Br J Anaesth; 2013 Oct; 111(4):667-72. PubMed ID: 23719767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic effects of intrathecally administered 26RFa, an intrinsic agonist for GPR103, on formalin test and carrageenan test in rats.
    Yamamoto T; Wada T; Miyazaki R
    Neuroscience; 2008 Nov; 157(1):214-22. PubMed ID: 18824219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered response to formalin by L5 spinal nerve ligation in rats: a behavioral and molecular study.
    Kaku R; Yokoyama M; Kobayashi H; Matsuoka Y; Sato T; Mizobuchi S; Itano Y; Morita K
    Anesth Analg; 2007 Apr; 104(4):936-43. PubMed ID: 17377110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered nociceptive response in mice deficient in the alpha(1B) subunit of the voltage-dependent calcium channel.
    Kim C; Jun K; Lee T; Kim SS; McEnery MW; Chin H; Kim HL; Park JM; Kim DK; Jung SJ; Kim J; Shin HS
    Mol Cell Neurosci; 2001 Aug; 18(2):235-45. PubMed ID: 11520183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-nociceptive effects of selectively destroying substance P receptor-expressing dorsal horn neurons using [Sar9,Met(O2)11]-substance P-saporin: behavioral and anatomical analyses.
    Wiley RG; Kline RH; Vierck CJ
    Neuroscience; 2007 May; 146(3):1333-45. PubMed ID: 17418497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the antinociceptive effect of systemic administration of tramadol and dexmedetomidine combination on rat models of acute and neuropathic pain.
    Guneli E; Karabay Yavasoglu NU; Apaydin S; Uyar M; Uyar M
    Pharmacol Biochem Behav; 2007 Nov; 88(1):9-17. PubMed ID: 17651791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of phosphorylated Ca2+/calmodulin-dependent protein kinase II and phosphorylated extracellular signal-regulated protein in the mouse formalin pain model.
    Choi SS; Seo YJ; Shim EJ; Kwon MS; Lee JY; Ham YO; Suh HW
    Brain Res; 2006 Sep; 1108(1):28-38. PubMed ID: 16863646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats.
    Honore P; Wismer CT; Mikusa J; Zhu CZ; Zhong C; Gauvin DM; Gomtsyan A; El Kouhen R; Lee CH; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
    J Pharmacol Exp Ther; 2005 Jul; 314(1):410-21. PubMed ID: 15837818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic pain in rats.
    Song XS; Cao JL; Xu YB; He JH; Zhang LC; Zeng YM
    Acta Pharmacol Sin; 2005 Jul; 26(7):789-98. PubMed ID: 15960884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of substance P and calcitonin gene-related peptide in development and maintenance of neuropathic pain from spinal nerve injury model of rat.
    Lee SE; Kim JH
    Neurosci Res; 2007 Jul; 58(3):245-9. PubMed ID: 17428562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel compound (+/-)-1-[10-((E)-3-Phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol.
    Munro G; Baek CA; Erichsen HK; Nielsen AN; Nielsen EØ; Scheel-Kruger J; Weikop P; Peters D
    Neuropharmacology; 2008 Feb; 54(2):331-43. PubMed ID: 18037451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tetramethylpyrazine on primary afferent transmission mediated by P2X3 receptor in neuropathic pain states.
    Gao Y; Xu C; Liang S; Zhang A; Mu S; Wang Y; Wan F
    Brain Res Bull; 2008 Sep; 77(1):27-32. PubMed ID: 18639742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution of primary sensory neurons and spinal glial cells to pathomechanisms of neuropathic pain].
    Obata K; Noguchi K
    Brain Nerve; 2008 May; 60(5):483-92. PubMed ID: 18516970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and T-type calcium channel blocking activity of novel diphenylpiperazine compounds, and evaluation of in vivo analgesic activity.
    Kam YL; Rhee HK; Rhim H; Back SK; Na HS; Choo HY
    Bioorg Med Chem; 2010 Aug; 18(16):5938-44. PubMed ID: 20659804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent analgesic effects of a putative sodium channel blocker M58373 on formalin-induced and neuropathic pain in rats.
    Akada Y; Ogawa S; Amano K; Fukudome Y; Yamasaki F; Itoh M; Yamamoto I
    Eur J Pharmacol; 2006 May; 536(3):248-55. PubMed ID: 16603152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.